A real-world Vestrum database analysis found pegcetacoplan was linked to better visual acuity outcomes in geographic atrophy, ...

High rates of noncompliance or nonpersistence with anti-vascular endothelial growth factor (VEGF) injections in neovascular ...

Real-world data indicate that pegcetacoplan treatment for GA may help patients avoid rapid and catastrophic visual acuity ...

Bispecific antibody fares well against faricimab, two gene therapies extend treatment inte ...

Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people ...

REGENXBIO Inc. RGNX on Saturday shared long-term clinical trial findings for its experimental gene therapy surabgene ...

Vonaprument reduced the proportion of eyes with clinically meaningful vision loss, though not uniformly across doses. Through ...

A Macon eye doctor says comprehensive exams can identify childhood vision problems that routine screenings or children ...

For adults with irregular corneas, a four-zone scleral lens demonstrates high effectiveness in improving visual performance, ...

ZOC2017217, an eye drop aimed at slowing or reversing the development of cataracts, is undergoing a pilot study ahead of a ...

Raleigh, NC - July 20, 2026 - PRESSADVANTAGE - Porter Ophthalmology, a LASIK and refractive surgery practice located in ...

D-150 gene therapy enters pivotal Wet-AMD/DME trials, cutting injections up to 89%. Click for this FDMT update.